Emerson Resources   Report issue

For profit Phase 2
Founded: Norristown PA United States (2002)

Organization Overview

First Clinical Trial
2018
NCT03304717
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Emerson Resources

Active Ingredients

Drugs in Phase 2 Trials (2)

emtricitabine (emtriva) (1 trial)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Autoimmune Diseases of the Nervous System (Phase 2)

Nervous System Malformations (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2